Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Plos One|September 5, 2009
Ensemble modeling for aromatic production in Escherichia coliMatthew L Rizk, James C LiaoBiophysical Journal|September 30, 2008
Ensemble modeling of metabolic networksLinh M Tran, Matthew L Rizk, James C LiaoClinical Pharmacology and Therapeutics|April 8, 2025
ASCPT 125th Anniversary: A Society Leadership PerspectiveMatthew L Rizk, Abigail Gorman, Sandra A G VisserMetabolic Engineering|April 22, 2009
Ensemble modeling for strain development of L-lysine-producing Escherichia coliCarolina A Contador, Matthew L Rizk, Juan A Asenjo, et al.Clinical Pharmacology in Drug Development|April 19, 2017
Single- and Multiple-Dose Pharmacokinetics of Once-Daily Formulations of RaltegravirRajesh Krishna, Matthew L Rizk, Patrick Larson, et al.Journal of Clinical Pharmacology|December 12, 2018
Simplification of Imipenem Dosing by Removal of Weight-Based AdjustmentsMallika Lala, Michelle Brown, Bhavna Kantesaria, et al.Biophysical Journal|April 23, 2010
Ensemble modeling of hepatic fatty acid metabolism with a synthetic glyoxylate shuntJason T Dean, Matthew L Rizk, Yikun Tan, et al.Biotechnology Progress|October 13, 2010
Redox homeostasis phenotypes in RubisCO-deficient Rhodobacter sphaeroides via ensemble modelingMatthew L Rizk, Rick Laguna, Kevin M Smith, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 12, 2018
Population pharmacokinetics of tazobactam/ceftolozane in Japanese patients with complicated urinary tract infection and complicated intra-abdominal infectionMakoto Kakara, Kajal Larson, Hwa-Ping Feng, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 4, 2019
A translational pharmacokinetic/pharmacodynamic model to characterize bacterial kill in the presence of imipenem-relebactamPratik Bhagunde, Zufei Zhang, Fred Racine, et al.Pageof 6